Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
about
Communicating mild cognitive impairment diagnoses with and without amyloid imaging.Alzheimer's disease CSF biomarkers: clinical indications and rational use.Alzheimer disease: CSF biomarkers for Alzheimer disease - approaching consensus.Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.Fluid biomarker agreement and interrelation in dementia due to Alzheimer's disease.Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease.When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression.Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.Molecular biomarkers of Alzheimer's disease: progress and prospects.Development of a High-Sensitivity Method for the Measurement of Human Nasal Aβ42, Tau, and Phosphorylated Tau.Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.Prediction of Cerebral Amyloid With Common Information Obtained From Memory Clinic Practice
P2860
Q33640373-C2F9FB9A-E2CD-4562-925B-470C9DBE688FQ38650548-82F581E1-CBA2-4136-9BCA-74413DB3BE57Q46523983-5F110C7C-F37B-44CB-AEB6-9AD7D5EE5BDFQ47288880-0771EDB1-1C9C-4AB3-B94E-0CD88B49E672Q47573970-3A99EB75-060B-4ECA-B38B-453654716425Q47697345-D0086D62-C337-41A2-945C-DDDF25D15856Q51741485-BC06DF2C-5AD2-4B8C-97B7-B6A266D374C7Q51760905-6E1010A9-553F-473D-A438-7B3C49F80E09Q53396427-8DAA3864-5031-4988-AD47-15A83A54D806Q53419197-37BD8A4B-354F-4A63-982B-7B1AAAC7E353Q54946040-F73CDAE1-D9E6-4427-B6D9-8C8EF1986BC7Q55177213-898AE3E2-A621-461F-B71A-0A2BD3C4CA38Q55383590-A6A51D89-BEBC-4C26-9821-F43AC3696F1EQ58585202-00C9E1EE-9BEA-459D-A2A2-C3F7FD149A48
P2860
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Recommendations for cerebrospi ...... of mild cognitive impairment.
@en
Recommendations for cerebrospi ...... of mild cognitive impairment.
@nl
type
label
Recommendations for cerebrospi ...... of mild cognitive impairment.
@en
Recommendations for cerebrospi ...... of mild cognitive impairment.
@nl
prefLabel
Recommendations for cerebrospi ...... of mild cognitive impairment.
@en
Recommendations for cerebrospi ...... of mild cognitive impairment.
@nl
P2093
P50
P921
P1476
Recommendations for cerebrospi ...... of mild cognitive impairment.
@en
P2093
Agnieszka Kulczyńska
Giovanni B Frisoni
Hanne Struyfs
Ines Baldeiras
Jose Luis Molinuevo
Juha O Rinne
Maria Bjerke
Markus Otto
Milica G Kramberger
P304
P356
10.1016/J.JALZ.2016.09.009
P50
P577
2016-10-27T00:00:00Z